Jun Kawashima

1.4k total citations
70 papers, 666 citations indexed

About

Jun Kawashima is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Jun Kawashima has authored 70 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 21 papers in Hematology and 18 papers in Oncology. Recurrent topics in Jun Kawashima's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Jun Kawashima is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Jun Kawashima collaborates with scholars based in United States, Japan and Italy. Jun Kawashima's co-authors include Vikas Gupta, Srđan Verstovšek, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, David Lavie, Uwe Platzbecker, Ruben A. Mesa, Francesco Passamonti, Claire Harrison and Hua Dong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jun Kawashima

52 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Kawashima United States 13 522 406 359 164 90 70 666
Emilie Leroy Belgium 13 514 1.0× 385 0.9× 315 0.9× 150 0.9× 139 1.5× 19 650
Cristina Panuzzo Italy 15 171 0.3× 316 0.8× 401 1.1× 49 0.3× 122 1.4× 49 644
Galit Granot Israel 13 103 0.2× 206 0.5× 290 0.8× 37 0.2× 83 0.9× 28 503
Yongwei Su China 13 82 0.2× 302 0.7× 563 1.6× 72 0.4× 86 1.0× 27 688
Ulrike Maegdefrau Germany 6 83 0.2× 135 0.3× 330 0.9× 24 0.1× 94 1.0× 9 579
Rita Andraos Switzerland 6 120 0.2× 98 0.2× 282 0.8× 30 0.2× 129 1.4× 7 411
Tianna Dauses United States 6 184 0.4× 483 1.2× 318 0.9× 14 0.1× 94 1.0× 8 630
Soizic Guihard France 10 134 0.3× 165 0.4× 157 0.4× 8 0.0× 73 0.8× 14 376
Malathi Kandarpa United States 9 51 0.1× 170 0.4× 335 0.9× 15 0.1× 155 1.7× 44 441
Dumitru Moldovan Romania 17 943 1.8× 275 0.7× 148 0.4× 375 2.3× 64 0.7× 36 1.0k

Countries citing papers authored by Jun Kawashima

Since Specialization
Citations

This map shows the geographic impact of Jun Kawashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Kawashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Kawashima more than expected).

Fields of papers citing papers by Jun Kawashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Kawashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Kawashima. The network helps show where Jun Kawashima may publish in the future.

Co-authorship network of co-authors of Jun Kawashima

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Kawashima. A scholar is included among the top collaborators of Jun Kawashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Kawashima. Jun Kawashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akabane, Miho, Jun Kawashima, Selamawit Woldesenbet, et al.. (2025). Preoperative diagnostic failure in gallbladder cancer: Influence of tumor location and size on imaging precision. European Journal of Surgical Oncology. 51(7). 109979–109979.
2.
Kawashima, Jun, Miho Akabane, Diamantis I. Tsilimigras, et al.. (2025). Oncologic impact of perineural invasion in perihilar cholangiocarcinoma: an international multicenter study. HPB. 27(9). 1158–1167.
3.
Kawashima, Jun & Timothy M. Pawlik. (2025). ASO Author Reflections: Composite Endpoint of Liver Surgery: Redefining Metrics for Clinical Trials. Annals of Surgical Oncology. 32(5). 3549–3550.
4.
Woldesenbet, Selamawit, et al.. (2025). New persistent opioid use among patients with behavioral health disorders following major surgery. Surgery. 181. 109305–109305.
5.
Khalil, Mujtaba, et al.. (2025). Impact of Academic Medical Centers on Surgical Outcomes of Neighboring Nonacademic Medical Centers. Journal of the American College of Surgeons. 240(4). 328–336.
6.
Kawashima, Jun, Andrea Baldo, George A. Poultsides, et al.. (2025). Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified tumor burden score. European Journal of Surgical Oncology. 51(12). 110527–110527.
7.
Kawashima, Jun, Yutaka Endo, Selamawit Woldesenbet, et al.. (2025). Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach. HepatoBiliary Surgery and Nutrition. 14(1). 3–15. 2 indexed citations
8.
Kawashima, Jun, Miho Akabane, & Timothy M. Pawlik. (2025). ASO Author Reflections: Occult Nodal Disease in Intrahepatic Cholangiocarcinoma—Implications of a Preoperative Inflammatory Biomarker. Annals of Surgical Oncology. 32(10). 7258–7259.
9.
Sahara, Kota, Diamantis I. Tsilimigras, Yuki Homma, et al.. (2024). Incidence and Prognostic Implications of Lymphovascular Invasion in Node‐Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group. Journal of Surgical Oncology. 131(3). 465–472. 2 indexed citations
10.
Kawashima, Jun, Miho Akabane, Yutaka Endo, et al.. (2024). Recurrence Timing and Risk Following Curative Resection of Colorectal Liver Metastases: Insights From a Hazard Function Analysis. Journal of Surgical Oncology. 131(5). 857–864. 2 indexed citations
11.
Akabane, Miho, Yuki Imaoka, Jun Kawashima, Austin Schenk, & Timothy M. Pawlik. (2024). Immunotherapy in liver transplantation for hepatocellular carcinoma: A comprehensive review. 17. 100256–100256. 1 indexed citations
12.
Catalano, Giovanni, et al.. (2024). Minimally invasive surgery approaches in major liver resection for hepatocellular carcinoma. Hepatoma Research. 1 indexed citations
13.
Oh, Stephen T., Srđan Verstovšek, Vikas Gupta, et al.. (2024). Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. SHILAP Revista de lepidopterología. 5(1). 105–116. 12 indexed citations
14.
15.
Kiladjian, Jean‐Jacques, Alessandro M. Vannucchi, Aaron T. Gerds, et al.. (2023). Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials. HemaSphere. 7(11). e963–e963. 10 indexed citations
16.
Verstovšek, Srđan, Ruben A. Mesa, Vikas Gupta, et al.. (2023). Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials. Blood Advances. 7(14). 3582–3591. 25 indexed citations
17.
Oh, Stephen T., Moshe Talpaz, Aaron T. Gerds, et al.. (2018). Hepcidin Suppression By Momelotinib Is Associated with Increased Iron Availability and Erythropoiesis in Transfusion-Dependent Myelofibrosis Patients. Blood. 132(Supplement 1). 4282–4282. 4 indexed citations
18.
Harrison, Claire, Alessandro M. Vannucchi, Uwe Platzbecker, et al.. (2017). Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial. The Lancet Haematology. 5(2). e73–e81. 212 indexed citations
19.
Kawashima, Jun, et al.. (2005). Structural, enzymatic and molecular studies in a series of nonbullous congenital ichthyosiform erythroderma patients. Clinical and Experimental Dermatology. 30(4). 429–431. 7 indexed citations
20.
Tanaka, Hirofumi, et al.. (1967). Two cases of human ophthalmic sparganosis especially on a branched plerocercoid.. Kiseichūgaku zasshi. 16(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilie Leroy Breakdown of academic impact, for papers by Cristina Panuzzo Breakdown of academic impact, for papers by Galit Granot Breakdown of academic impact, for papers by Yongwei Su Breakdown of academic impact, for papers by Ulrike Maegdefrau Breakdown of academic impact, for papers by Rita Andraos Breakdown of academic impact, for papers by Tianna Dauses Breakdown of academic impact, for papers by Soizic Guihard Breakdown of academic impact, for papers by Malathi Kandarpa Breakdown of academic impact, for papers by Dumitru Moldovan
Rankless by CCL
2026